Sign In
Buy MBXBF
$0.219
+0 (+0%)
At Close: Jun 22, 2026
Microbix Schedules Release of Results for Q2 Fiscal 2024
07:00am, Wednesday, 08'th May 2024
Results Release and Webinar Discussion on Morning of May 15, 2024 MISSISSAUGA, Ontario, May 08, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences
Microbix Presenting at the 2024 Bloom Burton Conference
07:00am, Thursday, 11'th Apr 2024
MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be atte
Microbix Announces Annual and Special Meeting Voting Results
07:00am, Monday, 01'st Apr 2024
MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the v
Microbix's Clot-Buster Drug Project Advances
07:00am, Thursday, 14'th Mar 2024
Sequel Pharma Executes Agreement with CDMO for Drug Substance Production Sequel Pharma Executes Agreement with CDMO for Drug Substance Production
Microbix Unveils Test Controls for Head and Neck Cancer
07:00am, Monday, 11'th Mar 2024
HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses
Microbix Announces Issuance of Stock Options
07:00am, Monday, 26'th Feb 2024
MISSISSAUGA, Ontario, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer and exporter, announces the issuance of
Microbix Biosystems Inc. (MBXBF) Q1 2024 Earnings Call Transcript
02:56pm, Wednesday, 14'th Feb 2024
Microbix Biosystems Inc. (MBXBF) Q1 2024 Earnings Call Transcript
Microbix Reports Record Results for Q1 Fiscal 2024
07:13am, Wednesday, 14'th Feb 2024
Record Revenues of $8.4 million and Record Net Income of $2.5 million Record Revenues of $8.4 million and Record Net Income of $2.5 million
Microbix Schedules Release of Results for Q1 Fiscal 2024
07:00am, Wednesday, 07'th Feb 2024
Results Release and Webinar Discussion on Morning of February 14, 2024 Results Release and Webinar Discussion on Morning of February 14, 2024
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen
07:00am, Tuesday, 06'th Feb 2024
MISSISSAUGA, Ontario, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it is pres
Microbix Biosystems Inc. (MBXBF) Q4 2023 Earnings Call Transcript
03:56pm, Wednesday, 03'rd Jan 2024
Microbix Biosystems Inc. (MBXBF) Q4 2023 Earnings Call Transcript
Microbix Achieves Further QAPs Sales Record
07:00am, Wednesday, 03'rd Jan 2024
Over C$ 1 Million in One Shipment to a Leading Lab Accreditation Agency Over C$ 1 Million in One Shipment to a Leading Lab Accreditation Agency
Microbix Reports Results for Q4 & Full-Year Fiscal 2023
08:03am, Thursday, 21'st Dec 2023
MISSISSAUGA, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its ye
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy
07:00am, Thursday, 14'th Dec 2023
Expanded Collaboration to Improve Syndromic Infectious Disease Testing Expanded Collaboration to Improve Syndromic Infectious Disease Testing
Microbix & BioGX Collaborate on real-time PCR Assays & Controls
07:00am, Thursday, 07'th Dec 2023
Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels
